Deferasirox Drug Interactions
Currently displaying 205 drugs known to have a major interaction with deferasirox.
- 205 major drug interactions
- 374 moderate drug interactions
- 12 minor drug interactions
Major interactions with deferasirox
Note: Showing generic names only.
A
- abciximab
- acalabrutinib
- adefovir
- ado-trastuzumab emtansine
- alendronate
- alteplase
- amikacin
- amikacin liposome
- aminophylline
- aminosalicylic acid
- amphotericin b
- amphotericin b cholesteryl sulfate
- amphotericin b lipid complex
- amphotericin b liposomal
- anagrelide
- anisindione
- anistreplase
- antithrombin (recombinant)
- antithrombin iii
- apixaban
- ardeparin
- argatroban
- aspirin
- avapritinib
B
- bacitracin
- balsalazide
- betamethasone
- betibeglogene autotemcel
- betrixaban
- binimetinib
- bismuth subsalicylate
- bivalirudin
- botulism immune globulin
- bromfenac
- busulfan
C
- cabozantinib
- cangrelor
- caplacizumab
- capreomycin
- celecoxib
- chloramphenicol
- choline salicylate
- cidofovir
- cilostazol
- cisplatin
- clopidogrel
- clozapine
- colistimethate
- cortisone
- cyclosporine
- cytomegalovirus immune globulin
D
- dabigatran
- dalteparin
- danaparoid
- daprodustat
- dasatinib
- defibrotide
- deflazacort
- desirudin
- dexamethasone
- diatrizoate
- diclofenac
- diclofenac topical
- dicumarol
- diflunisal
- dipyridamole
- drotrecogin alfa
E
- edoxaban
- encorafenib
- enoxaparin
- epoprostenol
- eptifibatide
- etidronate
- etodolac
- exagamglogene autotemcel
F
G
H
I
- ibandronate
- ibritumomab
- ibrutinib
- ibuprofen
- iloprost
- immune globulin intravenous
- immune globulin intravenous and subcutaneous
- indomethacin
- inotersen
- iobenguane I 131
- iodamide
- iodine i 131 tositumomab
- iodipamide
- iodixanol
- iohexol
- iomeprol
- iopamidol
- iopromide
- iothalamate
- ioversol
- ioxaglate
- ioxilan
K
L
- leflunomide
- lepirudin
- levoketoconazole
- lifileucel
- lithium
- lomitapide
- lovotibeglogene autotemcel
- lutetium lu 177 dotatate
- lutetium lu 177 vipivotide tetraxetan
M
- magnesium salicylate
- meclofenamate
- mefenamic acid
- meloxicam
- mesalamine
- methotrexate
- methoxyflurane
- methylprednisolone
- metrizamide
- mipomersen
- moxetumomab pasudotox
N
O
P
- pamidronate
- pentamidine
- pexidartinib
- phenylbutazone
- piroxicam
- plazomicin
- plicamycin
- polymyxin b
- ponatinib
- prasugrel
- prednisolone
- prednisone
R
- radium 223 dichloride
- ramucirumab
- rasagiline
- regorafenib
- resmetirom
- respiratory syncytial virus immune globulin
- reteplase
- rho (d) immune globulin
- risedronate
- rivaroxaban
- rofecoxib
- ruxolitinib
S
- salsalate
- selexipag
- selpercatinib
- sirolimus
- sodium salicylate
- sodium thiosalicylate
- streptokinase
- streptomycin
- sulfasalazine
- sulfinpyrazone
- sulindac
T
- tacrolimus
- telavancin
- temsirolimus
- tenecteplase
- tenofovir alafenamide
- tenofovir disoproxil
- teriflunomide
- theophylline
- ticagrelor
- ticlopidine
- tiludronate
- tinzaparin
- tirofiban
- tizanidine
- tobramycin
- tolmetin
- tositumomab
- tovorafenib
- treprostinil
- triamcinolone
- triamcinolone ophthalmic
U
V
W
Z
Deferasirox alcohol/food interactions
There are 2 alcohol/food interactions with deferasirox.
Deferasirox disease interactions
There are 6 disease interactions with deferasirox which include:
- bone marrow suppression
- dermatologic toxicities
- hepatic impairment
- renal dysfunction
- auditory and ocular abnormalities
- GI complication
More about deferasirox
- deferasirox consumer information
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (4)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: chelating agents
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.